Kelly Constable

Kelly Constable

Director/Board Member at ProTA Therapeutics Pty Ltd.

Health Technology
Finance
Technology Services

Profile

Ms. Kelly Constable is a Senior Advisor at Lumira Ventures and an Advisory Council at Medicines Australia.
She is on the Board of Directors at CERA Technologies Pty Ltd.
and ProTA Therapeutics Pty Ltd.
Ms. Constable was previously employed as a Venture partner by OneVentures Management Pty Ltd., a Board of Directors by Oculo Therapy LLC, a Chief strategy Officer by Omico Corp., a Board of Director & CEO by Genome One Pty Ltd., a Director of global marketing by Amgen AB, and a Senior product manager by Abbott Laboratories.
She received her undergraduate degree from the University of Tennessee.

Kelly Constable active positions

CompaniesPositionStart
Consultant / Advisor 01/08/2020
Director/Board Member 01/02/2020
Director/Board Member 01/10/2018
Director/Board Member -
All active positions of Kelly Constable

Former positions of Kelly Constable

CompaniesPositionEnd
Consultant / Advisor 02/10/2023
OMICO CORPORATION Corporate Officer/Principal 02/12/2019
Director/Board Member 02/12/2019
Genome One Pty Ltd. Chief Executive Officer 31/08/2018
Director/Board Member 02/12/2016
See the detail of Kelly Constable's experience

Training of Kelly Constable

University of Tennessee Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kelly Constable's experience

Connections

81

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ABBOTT LABORATORIES

Health Technology

OMICO CORPORATION

Finance

Private companies8

Health Technology

Technology Services

Health Technology

Genome One Pty Ltd.

Health Technology

Commercial Services

Finance

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Kelly Constable